Position in AZN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$459,556,324
New position
Shares Held
2,330,171
first reported quarter
Ownership
0.150%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026ACADIAN ASSET MANAGEMENT LLC holds $4,100,855,961 across 15 Drug Manufacturers - General names. AZN ranks #6 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
11,887,668 | $720,987,064 | |
| 2 | GSK |
GSK plc
|
11,797,085 | $651,081,121 | |
| 3 | MRK |
Merck & Co., Inc.
|
4,202,381 | $505,504,410 | |
| 4 | LLY |
ELI LILLY & Co
|
534,020 | $491,175,575 | |
| 5 | JNJ |
Johnson & Johnson
|
1,905,647 | $465,816,352 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
2,330,171 | $459,556,324 | |
| 7 | ABBV |
AbbVie Inc.
|
2,095,605 | $455,773,131 | |
| 8 | PFE |
Pfizer Inc
|
8,401,716 | $235,920,185 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $459,556,324 | 2,330,171 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||